about
Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistanceEvaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoringField evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Côte d'Ivoire.Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire.Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance SurveyComparison of Ahlstrom grade 226, Munktell TFN, and Whatman 903 filter papers for dried blood spot specimen collection and subsequent HIV-1 load and drug resistance genotyping analysis.Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey.Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission.Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.Human immunodeficiency virus Type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Côte d'Ivoire.Evaluation of blood collection filter papers for HIV-1 DNA PCR.Quantification of RNA in HIV type 1 subtypes D and G by NucliSens and Amplicor assays in Abidjan, Ivory Coast.Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, Cote d'Ivoire.Viral, HLA and T cell elements in cross-reactive immune responses to HIV-1 subtype A, CRF01_AE and CRF02_AG vaccine sequence in Ivorian blood donors.
P50
Q28534497-1D588472-9E3A-43F9-A041-04A27CAD9D1FQ28543688-5A9EFB3B-4003-4925-8006-7E7AD52B5F15Q35156162-9D1CC014-2149-45D1-8548-980AADE8FD0FQ39142666-8441B1A0-99CF-40F2-957F-88E0A734F6A9Q40794905-227D55CC-9208-450D-829E-A6834EDAD471Q40796505-7F5C7F83-67BC-4052-AFCD-E85A5E7C2A5EQ40797620-A70DF96E-18DD-4DF9-BA3B-6C90C750D7ADQ40799062-4991F221-5C7D-4325-8F92-A3D0BEF9CDD3Q45189387-E7FE3785-DA32-40C0-B95E-601E754EDD54Q45737845-BD704C81-3153-4FF7-B1D2-9542140DECC8Q46599881-C08E1655-B168-485B-9026-37397D33A434Q46680921-4D09A6CF-9B32-4768-83C8-8011D71E496DQ51573967-E6026F63-C599-49DE-B4DC-EA1DF7B906E2Q53465310-94DA4F7E-E3AB-4194-BAD9-21F2B7A838CD
P50
description
researcher, ORCID id # 0000-0003-1930-7443
@en
wetenschapper
@nl
name
Ebi Bile
@ast
Ebi Bile
@en
Ebi Bile
@es
Ebi Bile
@nl
type
label
Ebi Bile
@ast
Ebi Bile
@en
Ebi Bile
@es
Ebi Bile
@nl
prefLabel
Ebi Bile
@ast
Ebi Bile
@en
Ebi Bile
@es
Ebi Bile
@nl
P106
P1153
24480839000
P31
P496
0000-0003-1930-7443